Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jai Radhakrishnan

Showing results (161-170 of 225) with videos related to

Pageof 23
Sort By:
Clinical Nephrology|August 1, 2015
Predictors of outcome for severe IgA Nephropathy in a multi-ethnic U.S. cohortAna Huerta Arroyo, Andrew S Bomback, Blake Butler, et al.
Kidney International|April 15, 2021
Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazineDominick Santoriello, Andrew S Bomback, Satoru Kudose, et al.
Kidney International|April 20, 2025
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in ChildrenJürgen Floege, Keisha L Gibson, Marina Vivarelli, et al.
Kidney International Reports|February 12, 2024
Kidney Dysfunction and Pathology in the Setting of Hemophagocytic LymphohistiocytosisMiroslav Sekulic, Ibrahim Batal, Satoru Kudose, et al.
American Journal of Hematology|June 20, 2026
Long-Term Outcomes of Mayo Stage IIIb AL Amyloidosis Treated With Daratumumab-Based Frontline TherapySimon Zhen, Sorina Nicoleta Bandelita, Divaya Bhutani, et al.
Kidney International|June 6, 2003
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)Glen S Markowitz, Paul L Fine, Jay I Stack, et al.
JACC. Cardiovascular Interventions|February 22, 2020
The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of HypertensionMichael A Weber, Ajay J Kirtane, Matthew R Weir, et al.
Glomerular Diseases|February 11, 2026
Lived Experiences of Patients and Care Providers in Focal Segmental Glomerular Sclerosis and IgA NephropathyJai Radhakrishnan, Juan Carlos Julián Mauro, Emily Louise Thompson, et al.
Diabetes Care|April 30, 2003
Analysis of metabolic parameters as predictors of risk in the RENAAL studyGerald B Appel, Jai Radhakrishnan, Morrell M Avram, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2012
Eculizumab for dense deposit disease and C3 glomerulonephritisAndrew S Bomback, Richard J Smith, Gaetano R Barile, et al.
Pageof 23

Showing results (161-170 of 225) with videos related to

Sort By:
Pageof 23
Clinical Nephrology|August 1, 2015
Predictors of outcome for severe IgA Nephropathy in a multi-ethnic U.S. cohortAna Huerta Arroyo, Andrew S Bomback, Blake Butler, et al.
Kidney International|April 15, 2021
Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazineDominick Santoriello, Andrew S Bomback, Satoru Kudose, et al.
Kidney International|April 20, 2025
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in ChildrenJürgen Floege, Keisha L Gibson, Marina Vivarelli, et al.
Kidney International Reports|February 12, 2024
Kidney Dysfunction and Pathology in the Setting of Hemophagocytic LymphohistiocytosisMiroslav Sekulic, Ibrahim Batal, Satoru Kudose, et al.
American Journal of Hematology|June 20, 2026
Long-Term Outcomes of Mayo Stage IIIb AL Amyloidosis Treated With Daratumumab-Based Frontline TherapySimon Zhen, Sorina Nicoleta Bandelita, Divaya Bhutani, et al.
Kidney International|June 6, 2003
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)Glen S Markowitz, Paul L Fine, Jay I Stack, et al.
JACC. Cardiovascular Interventions|February 22, 2020
The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of HypertensionMichael A Weber, Ajay J Kirtane, Matthew R Weir, et al.
Glomerular Diseases|February 11, 2026
Lived Experiences of Patients and Care Providers in Focal Segmental Glomerular Sclerosis and IgA NephropathyJai Radhakrishnan, Juan Carlos Julián Mauro, Emily Louise Thompson, et al.
Diabetes Care|April 30, 2003
Analysis of metabolic parameters as predictors of risk in the RENAAL studyGerald B Appel, Jai Radhakrishnan, Morrell M Avram, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2012
Eculizumab for dense deposit disease and C3 glomerulonephritisAndrew S Bomback, Richard J Smith, Gaetano R Barile, et al.
Pageof 23